On the stock market since 2017, it operates in the world of health and science. It has 114 employees. Now — the numbers.
This is an established company with proven profits.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
An average decline of 79% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
If every debt were paid off today, $688 would still be left in the vault — a solid cushion for hard times.
Executives buying with their own money is usually read as confidence in the company’s future.
An investor who bought at the very peak is down 86% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
There is $3K in the vault; even if every debt were paid off, $688 would remain.
Over the last 12 months, company executives reported 9 buys and 2 sells. Management buying with its own money is usually read as a good sign.
Over the last 3 years, sales fell about 89% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.
The company’s market value is 1712 times its annual profit. Even a small disappointment could hit the price hard.
On our five-subject report card, RHE sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: RHE is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.